Evaluation of the Clinical Advantages of Laparoscopic Transverse Abdominal Wall Suspension in the Treatment of Pelvic Organ Prolapse

Abstract

Objective: To evaluate the clinical advantages of laparoscopic transverse abdominal wall suspension in treating pelvic organ prolapse. Methods: Sixty patients diagnosed with moderate to severe pelvic organ prolapse and underwent surgical treatment in our hospital between January 2022 and December 2023 were selected. According to different surgical methods, they were divided into an observation group (given laparoscopic transverse abdominal wall suspension) and a control group (given transvaginal mesh implantation), with 30 subjects/group. The data on perioperative-related indicators, quality of life scores, postoperative recurrence, and complications of the two groups of patients were collected. Results: The postoperative hospitalization days and intraoperative bleeding volume of the observation group were significantly lower than those of the control group, but had longer operation time than that of the control group (P < 0.05). The differences between the two groups were statistically significant 6 months after surgery, and the Pelvic Floor Disease Quality of Life Impact Questionnaire (PFIQ-7) score of the observation group was significantly higher than the control group (P < 0.05). Both groups of patients completed 12 months of follow-up without any postoperative recurrence. The number of complications in the observation group was slightly lower than that of the control group (P > 0.05). Conclusion: Laparoscopic transverse abdominal wall suspension was more effective in treating pelvic organ prolapse and is an ideal surgical procedure.